Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

NO CONTRAST TAVI

Paparoni Francesco Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini | De Remigis Franco Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo | Tomassoni Gianluca Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo | Marrangoni Alberto Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo | Marrone Gianluigi Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo | Fragassi Giovanni Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo | Lezzi Alessandro Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo | Fabiani Donatello Teramo (Teramo) – Uoc Cardiologia Utic Ed Emodinamica Ospedale Mazzini Teramo

 

 

BACKGROUND:

Chronic renal failure is a common comorbidity in patients undergoing TAVI.

Large amounts of contrast media are generally needed to safely perform TAVI with potential deleterious effects on renal function and long term life quality.

 

OBJECTIVES:

Every step of the procedure can be safely replaced by no contrast techniques: ultrasound guided vascular puncture and final check, alignement of 3 guides in Valsalva sinuses to check coplanarity or cusp overlap, coupling of hemodynamics and transthoracic echocardiography to check the results and need of postdilatation, measure of gradient across the arterial puncture to rule out iatrogenic stenosis.

 

MATHERIALS AND METHODS:

3 patients with severe renal failure (GFR < 30 ml/min/ 1.73 m2) and 1 patient with moderate renal failure and previous double renal transplantation underwent TAVI with protocol without contrast in our center in the last year. All cases were performed with local anesthesia and conscious sedation.

3 cases were performed with balloon expandable bioprosthesis and 1 with self expandable bioprosthesis.

 

RESULTS:

We were able to perform TAVI procedure without contrast in all 4 patients in which the technique was attempted without complications. Hemodynamics was excellent in all cases with no residual gradient or significant leaks. No vascular complication occured. Procedural time was generally 20% longer than average procedure but X rays dose exposure was reduced because less cine acquisitions were needed.

 

CONCLUSIONS:

TAVI with no use of contrast media is feasible and safe by extensive use of vascular ultrasound, hemodynamics, transthoracic echocardiography and multiple guides to depict coronary sinuses and assure correct prothesis implantation.